ACTIVELLA
LOE Approachingestradiol/norethindrone acetate
NDAORALTABLET
Approved
Nov 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
5/8 — Partial
ACTIVELLA (estradiol/norethindrone acetate) is estrogen receptor agonists [moa]. First approved in 1998.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTIVELLA is an oral tablet combining estradiol and norethindrone acetate, acting as estrogen receptor agonists to treat heavy menstrual bleeding, uterine fibroids, and endometriosis. It represents a hormone replacement approach to gynecological conditions affecting reproductive-age and perimenopausal women.
$0.125MPart D
LOE ApproachingDeclining
With LOE approaching and only $125K in Part D spending across 234 claims, ACTIVELLA is a declining-revenue brand with minimal team infrastructure and limited career growth potential.
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (5)
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Started Sep 2017
478 enrolled
Heavy Menstrual BleedingUterine Fibroids
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Started Feb 2016
378 enrolled
Uterine FibroidsHeavy Menstrual Bleeding
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Started Dec 2015
413 enrolled
Uterine FibroidsHeavy Menstrual Bleeding
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions
Started Feb 2007
36 enrolled
Healthy
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions
Started Jan 2007
40 enrolled
Healthy
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.